フィルター
3 件の結果が “64109” で取得されました
並べ替える:
アルファベット順（A-Z）
ベストセラー
hTSLPR
製品ID :
C001942
系統:
C57BL/6NCya
状況:
説明:
The CRLF2 (Cytokine Receptor Like Factor 2) gene encodes a type I cytokine receptor protein also known as the thymic stromal lymphopoietin receptor (TSLPR). This protein primarily functions by forming a heterodimeric complex with the interleukin-7 receptor alpha (IL7Rα), which, upon binding its ligand TSLP, activates the JAK/STAT (specifically JAK2, STAT3, and STAT5) and PI3K/AKT/mTOR signaling pathways to regulate hematopoietic cell proliferation, development, and immune homeostasis [1]. While physiological expression is most prominently labeled in lymphoid and myeloid-related tissues—including the bone marrow, thymus, spleen, and lungs, as well as specific cell types like dendritic cells, mast cells, and B-cell progenitors—it is also detected in the intestine and testis. Clinically, genetic rearrangements such as the P2RY8-CRLF2 fusion or IGH-CRLF2 translocation lead to CRLF2 overexpression, which is a hallmark of high-risk B-cell precursor acute lymphoblastic leukemia (B-ALL), particularly in children with Down syndrome [2]. Beyond oncology, dysregulated CRLF2 signaling is heavily implicated in inflammatory and allergic diseases, such as asthma and allergic rhinitis, where it drives Th2-mediated immune responses [3].
The hTSLPR mouse is a humanized model constructed through gene-editing technology, in which part of exon 1 to intron 7 of Mouse Crlf2 is replaced with Human CRLF2 CDS-Mouse Crlf2 CDS cassette. This model is applicable to research on B-cell precursor acute lymphoblastic leukemia (B-ALL) and inflammatory diseases, including asthma and allergic rhinitis. Furthermore, it supports the screening, development, and preclinical evaluation of TSLPR-targeted therapeutics.
The CRLF2 (Cytokine Receptor Like Factor 2) gene encodes a type I cytokine receptor protein also known as the thymic stromal lymphopoietin receptor (TSLPR). This protein primarily functions by forming a heterodimeric complex with the interleukin-7 receptor alpha (IL7Rα), which, upon binding its ligand TSLP, activates the JAK/STAT (specifically JAK2, STAT3, and STAT5) and PI3K/AKT/mTOR signaling pathways to regulate hematopoietic cell proliferation, development, and immune homeostasis [1]. While physiological expression is most prominently labeled in lymphoid and myeloid-related tissues—including the bone marrow, thymus, spleen, and lungs, as well as specific cell types like dendritic cells, mast cells, and B-cell progenitors—it is also detected in the intestine and testis. Clinically, genetic rearrangements such as the P2RY8-CRLF2 fusion or IGH-CRLF2 translocation lead to CRLF2 overexpression, which is a hallmark of high-risk B-cell precursor acute lymphoblastic leukemia (B-ALL), particularly in children with Down syndrome [2]. Beyond oncology, dysregulated CRLF2 signaling is heavily implicated in inflammatory and allergic diseases, such as asthma and allergic rhinitis, where it drives Th2-mediated immune responses [3].
The hTSLPR mouse is a humanized model constructed through gene-editing technology, in which part of exon 1 to intron 7 of Mouse Crlf2 is replaced with Human CRLF2 CDS-Mouse Crlf2 CDS cassette. This model is applicable to research on B-cell precursor acute lymphoblastic leukemia (B-ALL) and inflammatory diseases, including asthma and allergic rhinitis. Furthermore, it supports the screening, development, and preclinical evaluation of TSLPR-targeted therapeutics.
huTSLP/hTSLPR
製品ID :
C001991
系統:
C57BL/6NCya
状況:
説明:
The huTSLP/hTSLPR mice are a dual-gene humanized model obtained by mating huTSLP mice (catalog No.: C001809) with hTSLPR mice (catalog No.: C001942). This model can be used for the mechanism research and treatment development of allergic diseases, inflammation, and autoimmune diseases, as well as the development of TSLP/TSLPR-targeted drugs.
The huTSLP/hTSLPR mice are a dual-gene humanized model obtained by mating huTSLP mice (catalog No.: C001809) with hTSLPR mice (catalog No.: C001942). This model can be used for the mechanism research and treatment development of allergic diseases, inflammation, and autoimmune diseases, as well as the development of TSLP/TSLPR-targeted drugs.
huIL4/huIL4R/huTSLP/hTSLPR
製品ID :
C001996
系統:
C57BL/6NCya
状況:
説明:
The huIL4/huIL4R/huTSLP/hTSLPR mice are a quadruple-gene humanized model obtained by mating huIL4/huIL4R mice (catalog number: C001834), huTSLP mice (catalog number: C001809), and hTSLPR mice (catalog number: C001942). This model is a valuable tool for studying allergic diseases (such as asthma and atopic dermatitis), Th2 immune responses, parasitic infections, tumor immunology, and chronic inflammation. In addition, this model also provides a powerful preclinical research platform for evaluating the efficacy and mechanism of therapeutic drugs targeting IL4/IL4R/TSLP/TSLPR.
The huIL4/huIL4R/huTSLP/hTSLPR mice are a quadruple-gene humanized model obtained by mating huIL4/huIL4R mice (catalog number: C001834), huTSLP mice (catalog number: C001809), and hTSLPR mice (catalog number: C001942). This model is a valuable tool for studying allergic diseases (such as asthma and atopic dermatitis), Th2 immune responses, parasitic infections, tumor immunology, and chronic inflammation. In addition, this model also provides a powerful preclinical research platform for evaluating the efficacy and mechanism of therapeutic drugs targeting IL4/IL4R/TSLP/TSLPR.
Items: 1 to 3 of 3
1